Therapy features of interstitial lymphocytic lung disease (ILLD) in patients with immune dysregulation syndromes: case report

Cover Page

Cite item

Full Text

Abstract

Immune dysregulation syndromes (CTLA4 and LRBA deficiency) belong to the combined primary immunodeficiencies with defective tolerance due to lack of T regulatory lymphocytes function and resulting autoimmune complications. One of them is interstitial lymphocytic lung disease (ILLD), caused by pathologic bronchi-associated lymphoid tissue hyperplasia, progressive loss of lung function and decreased life expectancy. ILLD diagnosis is based on pathomorphological lung changes and radiologic symptoms. Targeted therapy with Abatacept in patients with immune dysregulation syndromes provides control of the autoimmune complications, including ILLD and is well tolerated. Here we demonstrate two cases of patients with immune dysregulation syndromes and ILLD treated with Abatacept.

About the authors

Y. A. Rodina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Author for correspondence.
Email: rodina.julija@rambler.ru
ORCID iD: 0000-0001-9857-4456

Julia A. Rodina, MD, allergologisimmunologist of the Immunology Department

117997, Moscow, Samory Mashela st., 1

Россия

A. L. Horeva

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

I. N. Abramova

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

O. A. Shvets

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0001-5347-7150
Россия

V. I. Burlakov

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

G. V. Tereshenko

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0001-7317-7104
Россия

D. S. Abramov

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0003-3664-2876
Россия

E. V. Deripapa

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-9083-4783
Россия

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 «D. Rogachev NMRCPHOI»

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.